Peter L. Hoang is President and CEO of Marker Therapeutics, Inc.. Currently has a direct ownership of 483,286 shares of MRKR, which is worth approximately $1.99 Million. The most recent transaction as insider was on Mar 24, 2022, when has been sold 48,376 shares (Common Stock) at a price of $0.48 per share, resulting in proceeds of $23,220. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 483K
0% 3M change
0% 12M change
Total Value Held $1.99 Million

Peter L. Hoang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2022
SELL
Payment of exercise price or tax liability
$23,220 $0.48 p/Share
48,376 Reduced 9.1%
483,286 Common Stock
Mar 24 2022
BUY
Grant, award, or other acquisition
-
199,094 Added 27.24%
531,662 Common Stock
Mar 16 2021
BUY
Open market or private purchase
$250,000 $1.75 p/Share
142,857 Added 30.05%
332,568 Common Stock
PLH

Peter L. Hoang

President and CEO
Houston, TX

Track Institutional and Insider Activities on MRKR

Follow Marker Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRKR shares.

Notify only if

Insider Trading

Get notified when an Marker Therapeutics, Inc. insider buys or sells MRKR shares.

Notify only if

News

Receive news related to Marker Therapeutics, Inc.

Track Activities on MRKR